Latest News

Deals this week: SciVision Biotech, Symic Biomedical, Palladio Biosciences

Taiwanese company SciVision Biotech intends to raise up to $30m in gross proceeds through a public offering of overseas secured convertible corporate...

Deals this week: SciVision Biotech, Symic Biomedical, Palladio Biosciences

Bioverativ to purchase True North Therapeutics for $400m

Global biotechnology company Bioverativ has entered a definitive agreement to acquire US-based company True North Therapeutics for...

Bioverativ to purchase True North Therapeutics for $400m

Unisys unveils PharmaTrack software to manage global pharmaceutical supply chain

Global information technology company Unisys has launched a new software to provide enhanced visibility and management of the entire pharmaceutical supply chain...

Unisys unveils PharmaTrack software to manage global pharmaceutical supply chain

FDA approves Sun Pharma’s tildrakizumab for moderate-to-severe plaque psoriasis

FDA approves Sun Pharma’s tildrakizumab for moderate-to-severe plaque psoriasis

UK CMA accuses Merck of breaking competition law with discount scheme

UK CMA accuses Merck of breaking competition law with discount scheme

Ardelyx’s first-in-class NHE3 blocker Tenapanor boasts positive phase III data

Ardelyx’s first-in-class NHE3 blocker Tenapanor boasts positive phase III data

FDA approves Sanofi and Regeneron’s Kevzara for adult rheumatoid arthritis

Sanofi and Regeneron Pharmaceuticals’ drug Kevzara (sarilumab) has received the US Food and Drug Administration (FDA) approval to treat adult patients affected with moderately to severely...

FDA approves Sanofi and Regeneron’s Kevzara for adult rheumatoid arthritis

Selexis and OSE Immunotherapeutics to support OSE-127 (Effi-7) development

Selexis and OSE Immunotherapeutics to support OSE-127 (Effi-7) development

AC Immune and Essex to develop biological treatment for neurodegenerative diseases

AC Immune and Essex to develop biological treatment for neurodegenerative diseases

Singapore eDevelopment subsidiary starts advanced research on Linebacker

Singapore eDevelopment subsidiary Global BioLife has started advanced research on a new universal therapeutic drug platform called Linebacker to tackle multiple conditions such as...

Singapore eDevelopment subsidiary starts advanced research on Linebacker

AstraZeneca signs deal to sell commercial rights for Seloken in Europe

AstraZeneca has entered an agreement to provide the commercial rights for Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax...

AstraZeneca signs deal to sell commercial rights for Seloken in Europe

Merck’s Isentress receives CHMP positive opinion to treat HIV-1 infection

Merck’s Isentress (raltegravir) 600mg film-coated tablets have received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA),...

Merck’s Isentress receives CHMP positive opinion to treat HIV-1 infection

Sanofi’s insulin lispro receives CHMP positive opinion to treat diabetes

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the marketing authorisation of Sanofi's insulin...

Sanofi’s insulin lispro receives CHMP positive opinion to treat diabetes

Cancer Research UK funded scientists to test Zika virus on brain tumours

Scientists funded by Cancer Research UK will investigate the effectiveness of the Zika virus in destroying brain tumour cells, which could lead to new treatments for...

Cancer Research UK funded scientists to test Zika virus on brain tumours

M&As this week: Lonza Group, Shandong Buchang Pharmaceutical

Swiss biopharmaceutical company Lonza Group has completed the acquisition of HansaBioMed Life Sciences OU, an Estonian pharmaceutical...

M&As this week: Lonza Group, Shandong Buchang Pharmaceutical

Sobi receives SFDA approval for Orfadin capsules

Sobi receives SFDA approval for Orfadin capsules

NPPA issues notice to pharmaceutical firms for non-compliance of pricing provisions

Indian drug price regulator the National Pharmaceutical Pricing Authority (NPPA) has issued notices to several pharmaceutical companies that have marketed combination drugs without complying...

NPPA issues notice to pharmaceutical firms for non-compliance of pricing provisions

Deals this week: Shanghai Fosun Pharmaceutical Group, Shandong Buchang Pharmaceutical, 4SC

Shanghai Fosun Pharmaceutical Group intends to raise approximately HK$2.32bn ($298.3m) through a private placement of 80.6 million...

Deals this week: Shanghai Fosun Pharmaceutical Group, Shandong Buchang Pharmaceutical, 4SC

ST Asia signs licensing agreement with PharmaMar for anti-cancer compound lurbinectedin

Singapore-based biopharmaceutical company Specialised Therapeutics Asia (ST Asia) will commercialise a new anti-cancer compound known as lurbinectedin (PM1183) throughout South East Asia,...

ST Asia signs licensing agreement with PharmaMar for anti-cancer compound lurbinectedin

X-Chem and Vertex form multi-target genetic disease collaboration

US-based firms X-Chem and Vertex Pharmaceuticals have signed a collaboration agreement to discover new drug leads against targets involved in multiple speciality...

X-Chem and Vertex form multi-target genetic disease collaboration

Bayer receives FDA priority review for copanlisib to treat follicular lymphoma

Bayer receives FDA priority review for copanlisib to treat follicular lymphoma
cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1460672566_rd1460672566_371857150_ap1460672566_1857678299_-520784304